All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as
of the end of the calendar quarter for which the report is filed, and the total market value. The market value
column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in
accounts.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Patrick Lai
CFO & CCO
San Francisco, California
2/14/2022
Note: The position in the shares of Class A Common Stock of Clover Health Investments, Corp. ("Clover") reported in this Form 13F Holdings Report and the Form 13F Holdings Reports filed by the Reporting Person for the quarters ended March 31, 2021, June 30, 2021 and September 30, 2021 were held in the form of shares of Class B Common Stock of Clover which are convertible into the shares of Class A Common Stock at the option of the holder and under certain other circumstances provided for in Clover's certificate of incorporation.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.